Shares of Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) fell 2.5% on Monday . The company traded as low as $4.61 and last traded at $4.72. 3,067,777 shares changed hands during trading, a decline of 29% from the average session volume of 4,294,800 shares. The stock had previously closed at $4.84.
Analyst Ratings Changes
Several research analysts have recently issued reports on TLRY shares. TD Securities raised Tilray Brands to a "strong-buy" rating in a research report on Friday, July 31st. TD Cowen reduced their price target on Tilray Brands from $7.00 to $5.00 and set a "buy" rating on the stock in a research note on Tuesday, July 14th. Wall Street Zen downgraded Tilray Brands from a "hold" rating to a "sell" rating in a report on Saturday, August 1st. Finally, Weiss Ratings reiterated a "sell (e+)" rating on shares of Tilray Brands in a report on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Tilray Brands presently has an average rating of "Moderate Buy" and a consensus target price of $11.00.
View Our Latest Research Report on Tilray Brands
Tilray Brands Trading Down 2.5%
The stock's fifty day simple moving average is $4.48 and its two-hundred day simple moving average is $5.80. The firm has a market cap of $642.88 million, a PE ratio of -4.37 and a beta of 1.90. The company has a quick ratio of 1.37, a current ratio of 2.21 and a debt-to-equity ratio of 0.22.
Tilray Brands (NASDAQ:TLRY - Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.42). Tilray Brands had a negative net margin of 13.11% and a negative return on equity of 7.76%. The business had revenue of $281.71 million for the quarter, compared to analysts' expectations of $246.30 million. On average, sell-side analysts forecast that Tilray Brands, Inc. will post -0.42 EPS for the current fiscal year.
Insider Buying and Selling at Tilray Brands
In related news, CFO Carl A. Merton purchased 10,000 shares of the stock in a transaction dated Tuesday, August 4th. The stock was purchased at an average price of $4.62 per share, with a total value of $46,200.00. Following the transaction, the chief financial officer directly owned 139,753 shares in the company, valued at $645,658.86. This trade represents a 7.71% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders acquired 15,000 shares of company stock worth $69,225 in the last ninety days. 0.84% of the stock is owned by company insiders.
Institutional Trading of Tilray Brands
Several institutional investors have recently bought and sold shares of the company. Hillsdale Investment Management Inc. bought a new position in shares of Tilray Brands in the fourth quarter worth approximately $4,855,000. IFP Advisors Inc increased its position in shares of Tilray Brands by 14.3% during the fourth quarter. IFP Advisors Inc now owns 60,318 shares of the company's stock valued at $545,000 after acquiring an additional 7,541 shares in the last quarter. State of New Jersey Common Pension Fund D purchased a new position in Tilray Brands in the 4th quarter worth approximately $346,000. Essential Partners LLC raised its holdings in Tilray Brands by 110,137.5% in the 1st quarter. Essential Partners LLC now owns 8,819 shares of the company's stock worth $57,000 after acquiring an additional 8,811 shares during the last quarter. Finally, Entropy Technologies LP bought a new position in Tilray Brands in the 1st quarter valued at approximately $123,000. 9.35% of the stock is owned by hedge funds and other institutional investors.
Tilray Brands Company Profile
(
Get Free Report)
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.